Cereno Scientific AB (publ)

OM:CRNO B Stock Report

Market Cap: SEK 1.4b

Cereno Scientific Future Growth

Future criteria checks 0/6

Cereno Scientific's revenue is forecast to decline at 171.4% per annum. EPS is expected to grow by 20.5% per annum.

Key information

n/a

Earnings growth rate

20.5%

EPS growth rate

Biotechs earnings growth49.2%
Revenue growth rate-171.4%
Future return on equityn/a
Analyst coverage

Low

Last updated12 Nov 2024

Recent future growth updates

No updates

Recent updates

Is Cereno Scientific (STO:CRNO B) Using Debt Sensibly?

Sep 26
Is Cereno Scientific (STO:CRNO B) Using Debt Sensibly?

Will Cereno Scientific (STO:CRNO B) Spend Its Cash Wisely?

Sep 01
Will Cereno Scientific (STO:CRNO B) Spend Its Cash Wisely?

We're Keeping An Eye On Cereno Scientific's (NGM:CRNO B) Cash Burn Rate

Apr 05
We're Keeping An Eye On Cereno Scientific's (NGM:CRNO B) Cash Burn Rate

Earnings and Revenue Growth Forecasts

OM:CRNO B - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025N/AN/AN/AN/A1
12/31/2024N/AN/AN/AN/A1
6/30/202469-69-118-49N/A
3/31/202455-59-102-46N/A
12/31/202349-48-86-37N/A
9/30/202353-35-83-30N/A
6/30/202358-31-93-35N/A
3/31/202365-27-86-21N/A
12/31/202258-28-76-19N/A
9/30/202252-23-74-22N/A
6/30/202251-19-79-9N/A
3/31/202249-18-64-16N/A
12/31/202145-16-58-13N/A
9/30/202131-17-44-13N/A
6/30/202123-17-15-12N/A
3/31/20219-16-23-14N/A
12/31/20208-16-24-16N/A
9/30/20200076N/A
6/30/2020-1076N/A
3/31/202001-3-3N/A
12/31/20190-1-1-1N/A
9/30/201910-16-32-22N/A
6/30/201910-16-32-20N/A
3/31/20199-15-19-9N/A
12/31/20187-12-17-9N/A
9/30/20186-9-15-7N/A
6/30/20189-8-16-7N/A
3/31/20189-6N/A-5N/A
12/31/20179-5N/A-4N/A
9/30/20179-4N/A-3N/A
6/30/20176-4N/A-5N/A
3/31/20176-6N/A-6N/A
12/31/20165-6N/A-5N/A
9/30/20163-5N/A-7N/A
6/30/20163-4N/A-4N/A
3/31/20161-1N/A-1N/A
12/31/201510N/A-1N/A
8/31/201500N/A0N/A
8/31/201410N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if CRNO B's forecast earnings growth is above the savings rate (1.2%).

Earnings vs Market: Insufficient data to determine if CRNO B's earnings are forecast to grow faster than the Swedish market

High Growth Earnings: Insufficient data to determine if CRNO B's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: CRNO B is forecast to have no revenue next year.

High Growth Revenue: CRNO B is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CRNO B's Return on Equity is forecast to be high in 3 years time


Discover growth companies